ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,131
Screening encounters
3,594
Diagnostic referrals
687
Outstanding pathways
262

Screening pathway

  1. Screening3,594Encounters
  2. Positive finding1,237Documented findings
  3. Referral687Diagnostic referrals
  4. Follow-up795Diagnostic visits
  5. Outcome425Resolved pathways

Stage totals use different units. Pending pathways: 262. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0164 · EXP-0164Synthetic · Site C

Full participant history through 2026-07-15, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-12-18
  4. · Diagnostic referral · EXP-0164-T-R
  5. · Contact attempt · Reached
  6. · Barrier documented · Transport difficulty
  7. · Diagnostic booking · Initial booking
  8. · Navigation intervention · Coordination support
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-09-10
  13. · Follow-up disposition · Resolved · EXP-0164-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3131 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0583 · Expanded synthetic participant 0583Site A — Urban Referral Hub
EXP-0584 · Expanded synthetic participant 0584Site C — Rural Outreach Programme
EXP-0585 · Expanded synthetic participant 0585Site B — Peri-Urban Access Programme
EXP-0586 · Expanded synthetic participant 0586Site A — Urban Referral Hub
EXP-0587 · Expanded synthetic participant 0587Site A — Urban Referral Hub
EXP-0588 · Expanded synthetic participant 0588Site D — Community Engagement Programme
EXP-0589 · Expanded synthetic participant 0589Site E — Resource-Constrained Navigation Programme
EXP-0590 · Expanded synthetic participant 0590Site D — Community Engagement Programme
EXP-0594 · Expanded synthetic participant 0594Site C — Rural Outreach Programme
EXP-0597 · Expanded synthetic participant 0597Site C — Rural Outreach Programme
EXP-0601 · Expanded synthetic participant 0601Site C — Rural Outreach Programme
EXP-0602 · Expanded synthetic participant 0602Site A — Urban Referral Hub
EXP-0603 · Expanded synthetic participant 0603Site C — Rural Outreach Programme
EXP-0604 · Expanded synthetic participant 0604Site B — Peri-Urban Access Programme
EXP-0608 · Expanded synthetic participant 0608Site E — Resource-Constrained Navigation Programme
EXP-0610 · Expanded synthetic participant 0610Site A — Urban Referral Hub
EXP-0612 · Expanded synthetic participant 0612Site E — Resource-Constrained Navigation Programme
EXP-0614 · Expanded synthetic participant 0614Site A — Urban Referral Hub
EXP-0615 · Expanded synthetic participant 0615Site E — Resource-Constrained Navigation Programme
EXP-0618 · Expanded synthetic participant 0618Site D — Community Engagement Programme
EXP-0620 · Expanded synthetic participant 0620Site C — Rural Outreach Programme
EXP-0621 · Expanded synthetic participant 0621Site D — Community Engagement Programme
EXP-0626 · Expanded synthetic participant 0626Site B — Peri-Urban Access Programme
EXP-0628 · Expanded synthetic participant 0628Site E — Resource-Constrained Navigation Programme
EXP-0632 · Expanded synthetic participant 0632Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1439
HPV DNA
1632
Cytology
523

Navigation activity

Barrier documented
588
Contact attempt
1012
Navigation intervention
246
Diagnostic booking
845
Diagnostic visit
795

Documented barriers

Contact difficulty
192
Transport difficulty
185
Appointment coordination
211

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.